This activity is jointly provided by Global Education Group and Integritas Communications.
This activity is supported by an educational grant from Gilead Sciences, Inc.
This two-part activity will provide continuing pharmacy education (CPE) to pharmacists who contribute or will contribute to HIV prevention, addressing knowledge and practice gaps identified among pharmacists and provide the clinical tools necessary for pharmacists to fulfill active roles within interdisciplinary HIV-prevention teams.
Online Monograph
Despite extensive HIV prevention efforts, rates of new diagnoses have not declined to the projected targets needed to end the HIV epidemic. Pharmacists have a critical role in the initiative to end the HIV epidemic and, therefore, must stay up to date on guidelines and protocols for HIV preexposure and postexposure prophylaxis (PrEP and PEP, respectively). This comprehensive electronic/downloadable monograph was developed specifically to support evolving and expanding needs of pharmacists. Recently, the pharmacy scope of practice has broadened in many states in the US, and this continuing education activity provides the necessary clinical information for initiating and monitoring PrEP and PEP treatment in the pharmacy setting. This monograph provides the education pharmacists need to incorporate the Centers for Disease Control and Prevention (CDC) 2021 Updated PrEP Clinical Practice Guidelines into their daily practice. In addition, with 2.0 contact hour(s) (0.20 CEUs) from the Accreditation Council for Pharmacy Education, this monograph addresses all content necessary for pharmacists wishing to become PrEP and PEP providers in order to fulfill most state board of pharmacy training requirements, such as:
- HIV epidemiology and burden
- Pharmacology, safety, and efficacy of HIV medications used for PrEP and PEP (including oral tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC), oral tenofovir alafenamide (TAF)/FTC, and cabotegravir long-acting injectable (CAB LAI))
- Assessment of sexual health and HIV risk
- Patient counseling
- Screening for HIV and sexually transmitted infections (STIs) and laboratory testing to determine PrEP/PEP eligibility
- 2021 CDC updated PrEP clinical practice guidelines for PrEP eligibility, prescribing, and management
- Clinical practice guidelines for nonoccupational PEP (nPEP) eligibility, prescribing, and management
- In-pharmacy implementation of both oral and LAI PrEP
- Trauma-informed care
Online Case-Based Skills Assessment
Pharmacists must expand their skills as new legislation in many states empowers them to add prescribing and provision of preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) to their practices. This case-based, online skills assessment activity is a supplement to the online monograph, Pharmacist-Led PEP/PrEP: A Comprehensive HIV Prevention Guide. In a series of three interactive cases, learners will apply their PrEP and PEP skills and knowledge to scenarios in a pharmacy setting.
Target Audience
Clinical and community pharmacists involved in the care of patients at risk for HIV infection.
